Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Juniper Pharmaceuticals, Inc

    Client Virtual Booth

    JUNIPER PHARMACEUTICALS, INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Juniper Pharmaceuticals, Inc
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    33 Arch Street, 31st Floor, Suite 3110, Boston, MA 02110
    Telephone
    Telephone
    +1 617 639 1500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.catalent.com/our-locations/europe/nottingham-uk/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/80680/
    Twitter
    Twitter
    https://twitter.com/juniperpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Juniper 5G Roamer to Surpass 200 Million by 2026 as Operators Accelerate Rollout
    Juniper 5G Roamer to Surpass 200 Million by 2026 as Operators Accelerate Rollout

    https://www.businesswire.com/news/home/20210725005002/en/Juniper-Research-5G-Roamers-to-Surpass-200-Million-by-2026-as-Operators-Pushed-to-Accelerate-Rollouts

    BUSINESSWIRE
    26 Jul 2021
    Share Share
    Biopharma Demand Continues to Influence CMO Actions
    Biopharma Demand Continues to Influence CMO Actions

    http://www.pharmtech.com/biopharma-demand-continues-influence-cmo-actions-0

    PHARMA TECH
    13 Sep 2018
    Share Share
    Catalent's growth blemished by weaker Softgel performance
    Catalent's growth blemished by weaker Softgel performance

    https://www.biopharmadive.com/news/catalents-growth-blemished-by-weaker-softgel-performance/531341/

    Jacob Bell BIOPHARMADIVE
    30 Aug 2018
    Share Share
    Catalent completes Juniper merger to ‘expand and strengthen’ oral dose mfg
    Catalent completes Juniper merger to ‘expand and strengthen’ oral dose mfg

    https://www.in-pharmatechnologist.com/Article/2018/08/14/Catalent-completes-Juniper-merger-to-expand-and-strengthen-oral-dose-manufacturing

    Flora Southey IN-PHARMATECHNOLOGIST
    15 Aug 2018
    Share Share
    API manufacturer Cambrex buys Halo Pharma for $425M
    API manufacturer Cambrex buys Halo Pharma for $425M

    https://endpts.com/api-manufacturer-cambrex-buys-halo-pharma-for-425m-venturing-into-finished-dose-manufacturing/

    Amber Tong ENDPTS
    25 Jul 2018
    Share Share
    Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK Dev
    Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK Dev

    https://endpts.com/catalent-inks-133m-deal-to-buy-juniper-pharmaceuticals-adding-uk-development-services/

    John Carroll ENDPTS
    03 Jul 2018
    Share Share
    Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.
    Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

    https://www.businesswire.com/news/home/20180703005086/en

    BUSINESSWIRE
    03 Jul 2018
    Share Share
    Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors
    Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors

    https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-appoints-richard-messina-to-board-of-directors-300617302.html

    PRNEWSWIRE
    21 Mar 2018
    Share Share
    Juniper Pharmaceuticals to Explore Strategic Alternatives
    Juniper Pharmaceuticals to Explore Strategic Alternatives

    https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-explore-strategic-alternatives-300590868.html

    PR NEWSWIRE
    31 Jan 2018
    Share Share
    Juniper Announces 4.5-Y Extension through 2024 of CRINONE®sAgreement Merck KGaA
    Juniper Announces 4.5-Y Extension through 2024 of CRINONE®sAgreement Merck KGaA

    https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-announces-45-year-extension-through-2024-of-crinone-supply-agreement-with-merck-kgaa-darmstadt-germany-300578786.html

    PR NEWSWIRE
    08 Jan 2018
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search